Sanai Health Industry Group Company Limited (HKG:1889)
Hong Kong · Delayed Price · Currency is HKD 0.1950
+0.0050 (2.63%)
Sep 15, 2026, 1:02 PM HKT
HKG:1889 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 82.6 | 85.9 | 85.22 | 107.77 | 175.92 | 67.61 | |
Revenue Growth | -13.70% | 0.80% | -20.92% | -38.74% | 160.21% | -44.31% |
Cost of Revenue | 62.09 | 71.57 | 68.35 | 78.6 | 84.41 | 27.16 |
Gross Profit | 20.52 | 14.33 | 16.86 | 29.17 | 91.51 | 40.45 |
Selling, General & Admin | 38.71 | 37.29 | 32.31 | 14.17 | 19.11 | 14.84 |
Operating Expenses | 38.82 | 37.41 | 31.51 | 10.74 | 32.16 | 15.72 |
Operating Income | -18.31 | -23.08 | -14.65 | 18.43 | 59.35 | 24.72 |
Interest Expense | -2.98 | -2.82 | -2.2 | -2.03 | -1.79 | - |
Interest & Investment Income | 0.16 | 0.16 | 0.57 | 0.44 | 0.08 | 0.71 |
Earnings From Equity Investments | -0.77 | -0.63 | -0.46 | - | - | - |
Currency Exchange Gain (Loss) | - | - | 2.52 | - | - | 0.05 |
Other Non Operating Income (Expenses) | 2.38 | 1.15 | 1.4 | -0.02 | 2.03 | 0.01 |
EBT Excluding Unusual Items | -19.52 | -25.22 | -12.82 | 16.83 | 59.67 | 25.5 |
Gain (Loss) on Sale of Investments | -1.04 | -1.04 | - | - | - | - |
Gain (Loss) on Sale of Assets | -1.37 | -0.76 | -0.12 | - | -2.48 | - |
Other Unusual Items | 0.02 | 0.02 | - | 2.55 | -1.41 | - |
Pretax Income | -21.9 | -27 | -12.94 | 19.38 | 55.77 | 25.5 |
Income Tax Expense | -0.76 | -0.46 | 0.97 | 8.44 | 20.57 | 8.63 |
Earnings From Continuing Operations | -21.14 | -26.54 | -13.91 | 10.94 | 35.2 | 16.88 |
Earnings From Discontinued Operations | - | - | 17.31 | 2.43 | - | - |
Net Income to Company | -21.14 | -26.54 | 3.4 | 13.37 | 35.2 | 16.88 |
Minority Interest in Earnings | 1.66 | 4.5 | 1.49 | 5.27 | -5.98 | -7.85 |
Net Income | -19.49 | -22.04 | 4.89 | 18.63 | 29.22 | 9.03 |
Net Income to Common | -19.49 | -22.04 | 4.89 | 18.63 | 29.22 | 9.03 |
Net Income Growth | - | - | -73.75% | -36.23% | 223.73% | 40.53% |
Shares Outstanding (Basic) | 153 | 153 | 145 | 128 | 123 | 123 |
Shares Outstanding (Diluted) | 153 | 153 | 145 | 152 | 144 | 123 |
Shares Change | -0.03% | 5.20% | -4.19% | 5.08% | 17.66% | - |
EPS (Basic) | -0.13 | -0.14 | 0.03 | 0.15 | 0.24 | 0.07 |
EPS (Diluted) | -0.13 | -0.14 | 0.03 | 0.13 | 0.22 | 0.07 |
EPS Growth | - | - | -73.55% | -43.10% | 208.51% | 38.51% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -54.22 | 10.63 | 320.61 | -56.22 | -38.81 |
Free Cash Flow Per Share | - | -0.35 | 0.07 | 2.11 | -0.39 | -0.32 |
Gross Margin | 24.84% | 16.69% | 19.79% | 27.07% | 52.02% | 59.82% |
Operating Margin | -22.17% | -26.86% | -17.19% | 17.11% | 33.73% | 36.57% |
Profit Margin | -23.59% | -25.66% | 5.74% | 17.29% | 16.61% | 13.35% |
Free Cash Flow Margin | - | -63.12% | 12.47% | 297.50% | -31.95% | -57.40% |
EBITDA | -15.64 | -20.57 | -12.54 | 21.56 | 62.59 | 28.14 |
EBITDA Margin | -18.94% | -23.95% | -14.72% | 20.01% | 35.58% | 41.62% |
D&A For EBITDA | 2.67 | 2.5 | 2.1 | 3.13 | 3.24 | 3.41 |
EBIT | -18.31 | -23.08 | -14.65 | 18.43 | 59.35 | 24.72 |
EBIT Margin | -22.17% | -26.86% | -17.19% | 17.11% | 33.73% | 36.57% |
Effective Tax Rate | - | - | - | 43.55% | 36.89% | 33.82% |